← Open Payments lookup

ALLISON SCHULER: Open Payments

NPI 1548924905 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$402 in 12 payments from 10 companies in 2025. Trend: 2023 $30 · 2024 $15 · 2025 $402

Food & beverage: $402
CompanyPaymentsAmount
Exelixis Inc.2$148
PharmaEssentia USA Corporation2$51
Janssen Biotech, Inc.1$37
AstraZeneca Pharmaceuticals LP1$34
Bayer Healthcare Pharmaceuticals Inc.1$29
Lilly USA, LLC1$28
SOBI, INC1$22
Astellas Pharma US Inc1$19
Deciphera Pharmaceuticals Inc.1$18
Gilead Sciences, Inc.1$17

Products named: CABOMETYX, BESREMI, RYBREVANT, CALQUENCE, Nubeqa, VERZENIO, Doptelet, Vyloy.

Industry payments across MD — which companies pay providers there.